233(top 1%)
PR articles
10.9K(top 1%)
PR citations
48(top 1%)
PR h-index
52(top 1%)
h-index
255
documents
14.4K
doc citations
2.4K
citing journals
100
times ranked

Publications

237 PR articles • 11,672 PR citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk2.90Citations (PDF)
2Smart Nonuniformity for Calibrating Sequencing Depth of a Targeted Gene Panel to Simultaneously Detect Somatic and Germline Variants2.50Citations (PDF)
3Genetic and Environmental Causes of Variation in an Automated Breast Cancer Risk Factor Based on Mammographic Textures1.11Citations (PDF)
4Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes13.715Citations (PDF)
5Self-rated health, epigenetic ageing, and long-term mortality in older Australians
GeroScience, 2024, 46, 5505-5515
4.64Citations (PDF)
6Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel6.563Citations (PDF)
7Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk
JAMA Network Open, 2024, 7, e2427441
6.65Citations (PDF)
8Dietary factors and DNA methylation-based markers of ageing in 5310 middle-aged and older Australian adults
GeroScience, 2024, 47, 1685-1698
4.64Citations (PDF)
9Region-Based Analyses of Existing Genome-Wide Association Studies Identifies Novel Potential Genetic Susceptibility Regions for Glioma
Cancer Research Communications, 2024, 4, 2933-2946
2.81Citations (PDF)
10Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men
Human Molecular Genetics, 2023, 32, 489-495
2.98Citations (PDF)
11Epigenome-wide association study of short-term temperature fluctuations based on within-sibship analyses in Australian females
Environment International, 2023, 171, 107655
10.25Citations (PDF)
12Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer4.315Citations (PDF)
13The impact of coding germline variants on contralateral breast cancer risk and survival6.518Citations (PDF)
14Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Journal of Medical Genetics, 2023, 60, 1186-1197
3.83Citations (PDF)
15Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Nature Genetics, 2023, 55, 2065-2074
25.2122Citations (PDF)
16Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries4.959Citations (PDF)
17Association of Markers of Inflammation, the Kynurenine Pathway and B Vitamins with Age and Mortality, and a Signature of Inflammaging3.544Citations (PDF)
18Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants
Genetics in Medicine, 2022, 24, 119-129
4.228Citations (PDF)
19Value of the loss of heterozygosity to BRCA1 variant classification6.48Citations (PDF)
20Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts*
British Journal of Dermatology, 2022, 186, 823-834
1.719Citations (PDF)
21Early life affects late-life health through determining DNA methylation across the lifespan: A twin study
EBioMedicine, 2022, 77, 103927
9.732Citations (PDF)
22A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women2.810Citations (PDF)
23Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC)
Cancer Prevention Research, 2022, 15, 185-191
1.55Citations (PDF)
24Within-sibship genome-wide association analyses decrease bias in estimates of direct genetic effects
Nature Genetics, 2022, 54, 581-592
25.2327Citations (PDF)
25Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking5.39Citations (PDF)
26Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies4.638Citations (PDF)
27Women's thoughts on receiving and sharing genetic information: Considerations for genetic counseling
Journal of Genetic Counseling, 2022, 31, 1249-1260
1.71Citations (PDF)
28Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium1.747Citations (PDF)
29Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
Nature Genetics, 2022, 55, 89-99
25.2194Citations (PDF)
30Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer4.355Citations (PDF)
31Methylation marks of prenatal exposure to maternal smoking and risk of cancer in adulthood4.925Citations (PDF)
32Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort4.615Citations (PDF)
33DNA Methylation in Peripheral Blood and Risk of Gastric Cancer: A Prospective Nested Case–control Study
Cancer Prevention Research, 2021, 14, 233-240
1.56Citations (PDF)
34Alcohol consumption is associated with widespread changes in blood DNA methylation: Analysis of cross‐sectional and longitudinal data
Addiction Biology, 2021, 26,
2.681Citations (PDF)
35The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial
Endoscopic Ultrasound, 2021, 10, 335
2.97Citations (PDF)
36Association of variably methylated tumour DNA regions with overall survival for invasive lobular breast cancer3.918Citations (PDF)
37Epigenetic Drift Association with Cancer Risk and Survival, and Modification by Sex
Cancers, 2021, 13, 1881
3.811Citations (PDF)
38Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects6.412Citations (PDF)
39DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer
Cancers, 2021, 13, 2589
3.829Citations (PDF)
40Transcriptomic changes in peripheral blood mononuclear cells with weight loss: systematic literature review and primary data synthesis4.313Citations (PDF)
41Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus
Human Genetics, 2021, 140, 1353-1365
2.932Citations (PDF)
42Independent prognostic impact of plasma NCOA2 alterations in metastatic castration‐resistant prostate cancer
Prostate, 2021, 81, 992-1001
2.18Citations (PDF)
43Inflammation-Related Marker Profiling of Dietary Patterns and All-cause Mortality in the Melbourne Collaborative Cohort Study
Journal of Nutrition, 2021, 151, 2908-2916
2.923Citations (PDF)
44Surrounding Greenness and Biological Aging Based on DNA Methylation: A Twin and Family Study in Australia8.424Citations (PDF)
45Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer12.635Citations (PDF)
46Ambient temperature and genome-wide DNA methylation: A twin and family study in Australia
Environmental Pollution, 2021, 285, 117700
7.718Citations (PDF)
47Residential surrounding greenness and DNA methylation: An epigenome-wide association study
Environment International, 2021, 154, 106556
10.231Citations (PDF)
48Smoking Methylation Marks for Prediction of Urothelial Cancer Risk1.15Citations (PDF)
491322A pilot study of faecal sample collection from prospective cohort study participants4.90Citations (PDF)
50Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium1.135Citations (PDF)
51Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study2.977Citations (PDF)
52Prospective Evaluation over 15 Years of Six Breast Cancer Risk Models
Cancers, 2021, 13, 5194
3.88Citations (PDF)
53Repeatability of methylation measures using a QIAseq targeted methyl panel and comparison with the Illumina HumanMethylation450 assay
BMC Research Notes, 2021, 14,
1.54Citations (PDF)
54Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk2.94Citations (PDF)
55Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness
Cancer Research, 2020, 80, 624-638
3.848Citations (PDF)
56Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation Results4.61Citations (PDF)
57Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk
Cancer Research, 2020, 80, 116-125
3.850Citations (PDF)
58Smoking and blood DNA methylation: an epigenome-wide association study and assessment of reversibility
Epigenetics, 2020, 15, 358-368
3.081Citations (PDF)
59Overall lack of replication of associations between dietary intake of folate and vitamin B-12 and DNA methylation in peripheral blood4.77Citations (PDF)
60Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk3.966Citations (PDF)
61Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location2.918Citations (PDF)
62Stochastic Epigenetic Mutations Are Associated with Risk of Breast Cancer, Lung Cancer, and Mature B-cell Neoplasms1.128Citations (PDF)
63Genetic and environmental causes of variation in epigenetic aging across the lifespan3.962Citations (PDF)
64Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants
JAMA Oncology, 2020, 6, 1218
14.461Citations (PDF)
65Palm reading and water divining: A cross-sectional study of the accuracy of palmar hyperlinearity and transepidermal water loss to identify individuals with a filaggrin gene null mutation1.83Citations (PDF)
66Novel Common Genetic Susceptibility Loci for Colorectal Cancer4.6155Citations (PDF)
67Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool2.910Citations (PDF)
68A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
JAMA Oncology, 2019, 5, 1718
14.4121Citations (PDF)
69Body size and dietary risk factors for aggressive prostate cancer: a case–control study
Cancer Causes and Control, 2019, 30, 1301-1312
1.73Citations (PDF)
70Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study4.853Citations (PDF)
71Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk3.926Citations (PDF)
72Dietary Intake of Nutrients Involved in One-Carbon Metabolism and Risk of Gastric Cancer: A Prospective Study
Nutrition and Cancer, 2019, 71, 605-614
2.422Citations (PDF)
73Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report
Journal of Medical Genetics, 2019, 56, 453-460
3.841Citations (PDF)
74Autologous platelet‐rich plasma for healing chronic venous leg ulcers: Clinical efficacy and potential mechanisms
International Wound Journal, 2019, 16, 788-792
3.116Citations (PDF)
75Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort4.314Citations (PDF)
7610-year performance of four models of breast cancer risk: a validation study
Lancet Oncology, The, 2019, 20, 504-517
27.4143Citations (PDF)
77Physical Activity, Television Viewing Time, and DNA Methylation in Peripheral Blood0.819Citations (PDF)
78Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)4.846Citations (PDF)
79Circulating concentrations of B group vitamins and urothelial cell carcinoma
International Journal of Cancer, 2019, 144, 1909-1917
4.310Citations (PDF)
80Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk4.638Citations (PDF)
81Dietary intake of nutrients involved in one‐carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study4.314Citations (PDF)
82Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases4.09Citations (PDF)
83Association of DNA Methylation-Based Biological Age With Health Risk Factors and Overall and Cause-Specific Mortality3.3136Citations (PDF)
84Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype4.396Citations (PDF)
85DNA methylation‐based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies
International Journal of Cancer, 2018, 142, 1611-1619
4.3208Citations (PDF)
86Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1
Genetics in Medicine, 2018, 20, 890-895
4.254Citations (PDF)
87Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)4.870Citations (PDF)
88Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds4.826Citations (PDF)
89Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study2.942Citations (PDF)
90sEst: Accurate Sex-Estimation and Abnormality Detection in Methylation Microarray Data4.48Citations (PDF)
91Genome-wide average DNA methylation is determined in utero4.942Citations (PDF)
92Heritable methylation marks associated with breast and prostate cancer risk
Prostate, 2018, 78, 962-969
2.121Citations (PDF)
93FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine1.823Citations (PDF)
94The utility of DNA extracted from saliva for genome-wide molecular research platforms
BMC Research Notes, 2018, 11,
1.531Citations (PDF)
95Epigenetic supersimilarity of monozygotic twin pairs
Genome Biology, 2018, 19,
8.1105Citations (PDF)
96Dietary intake of one-carbon metabolism nutrients and DNA methylation in peripheral blood4.746Citations (PDF)
97Inference about causation between body mass index and DNA methylation in blood from a twin family study3.054Citations (PDF)
98Cohort Profile: The Tasmanian Longitudinal Health STUDY (TAHS)4.926Citations (PDF)
99Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
British Journal of Cancer, 2017, 116, 524-535
5.526Citations (PDF)
100Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM study
Familial Cancer, 2017, 16, 411-416
1.46Citations (PDF)
101Genome‐Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case‐Control Study
Prostate, 2017, 77, 471-478
2.136Citations (PDF)
102Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia13.796Citations (PDF)
103Association between DNA methylation at SOCS3 gene and body mass index might be due to familial confounding3.017Citations (PDF)
104Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case–control study4.011Citations (PDF)
105Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers16.62,546Citations (PDF)
106Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study1.819Citations (PDF)
107Twin birth changes DNA methylation of subsequent siblings3.410Citations (PDF)
108Causes of blood methylomic variation for middle-aged women measured by the HumanMethylation450 array
Epigenetics, 2017, 12, 973-981
3.014Citations (PDF)
109Characterisation of microbial communities within aggressive prostate cancer tissues2.567Citations (PDF)
110DNA methylation changes measured in pre‐diagnostic peripheral blood samples are associated with smoking and lung cancer risk4.3127Citations (PDF)
111Body mass index and breast cancer survival: a Mendelian randomization analysis4.953Citations (PDF)
112Mammographic density and risk of breast cancer by tumor characteristics: a case-control study
BMC Cancer, 2017, 17,
2.98Citations (PDF)
113Novel associations between blood DNA methylation and body mass index in middle-aged and older adults3.076Citations (PDF)
114DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry
Anticancer Research, 2017, 37, 659-664
1.19Citations (PDF)
115Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges2.324Citations (PDF)
116Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS ONE, 2016, 11, e0158801
2.312Citations (PDF)
117Mould‐sensitized adults have lower Th2 cytokines and a higher prevalence of asthma than those sensitized to other aeroallergens6.85Citations (PDF)
118Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study4.836Citations (PDF)
119Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus4.837Citations (PDF)
120Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/24.896Citations (PDF)
121Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case–control study
British Journal of Cancer, 2016, 115, 664-673
5.540Citations (PDF)
122Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women4.863Citations (PDF)
123Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer13.7103Citations (PDF)
124Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia13.7109Citations (PDF)
125Reliability of DNA methylation measures from dried blood spots and mononuclear cells using the HumanMethylation450k BeadArray3.472Citations (PDF)
126Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH
International Journal of Cancer, 2016, 139, 1557-1563
4.3138Citations (PDF)
127Global Measures of Peripheral Blood-Derived DNA Methylation as a Risk Factor in the Development of Mature B-Cell Neoplasms
Epigenomics, 2016, 8, 55-66
2.237Citations (PDF)
128Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients
Gynecologic Oncology, 2016, 141, 318-322
3.018Citations (PDF)
129Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families3.872Citations (PDF)
130Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.32.420Citations (PDF)
131A prospective study of peripheral blood DNA methylation at RPTOR, MGRN1 and RAPSN and risk of breast cancer2.49Citations (PDF)
132Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry2.433Citations (PDF)
133Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts13.7215Citations (PDF)
134Genome-Wide Association Study of Prostate Cancer–Specific Survival1.128Citations (PDF)
135Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots
Analytical Biochemistry, 2015, 470, 48-51
2.48Citations (PDF)
136A Genome-Wide “Pleiotropy Scan” Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer
PLoS ONE, 2014, 9, e85955
2.38Citations (PDF)
137Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
British Journal of Cancer, 2014, 110, 1367-1377
5.557Citations (PDF)
138DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS Genetics, 2014, 10, e1004256
3.255Citations (PDF)
139Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia4.8110Citations (PDF)
140Breast-Cancer Risk in Families With Mutations in PALB20.51Citations (PDF)
141DNA mismatch repair gene MSH6 implicated in determining age at natural menopause
Human Molecular Genetics, 2014, 23, 2490-2497
2.965Citations (PDF)
142Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers4.863Citations (PDF)
143Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Carcinogenesis, 2014, 35, 1012-1019
2.8159Citations (PDF)
144Associations of Mammographic Dense and Nondense Areas and Body Mass Index With Risk of Breast Cancer3.355Citations (PDF)
145Should the grading of colorectal adenocarcinoma include microsatellite instability status?
Human Pathology, 2014, 45, 2077-2084
2.346Citations (PDF)
146FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
British Journal of Cancer, 2014, 110, 1088-1100
5.522Citations (PDF)
147Detection of infectious organisms in archival prostate cancer tissues
BMC Cancer, 2014, 14,
2.933Citations (PDF)
148A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Nature Genetics, 2014, 46, 1103-1109
25.2432Citations (PDF)
149Comparison of mRNA Splicing Assay Protocols across Multiple Laboratories: Recommendations for Best Practice in Standardized Clinical Testing
Clinical Chemistry, 2014, 60, 341-352
1.1100Citations (PDF)
150COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration4.839Citations (PDF)
151FAVR (Filtering and Annotation of Variants that are Rare): methods to facilitate the analysis of rare germline genetic variants from massively parallel sequencing datasets
BMC Bioinformatics, 2013, 14,
3.010Citations (PDF)
152The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array
BMC Biotechnology, 2013, 13,
2.972Citations (PDF)
153Tumour morphology predicts PALB2 germline mutation status
British Journal of Cancer, 2013, 109, 154-163
5.519Citations (PDF)
154Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant2.410Citations (PDF)
155Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB21.715Citations (PDF)
156Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
British Journal of Cancer, 2013, 109, 1296-1301
5.546Citations (PDF)
157Cross-platform compatibility of Hi-Plex, a streamlined approach for targeted massively parallel sequencing
Analytical Biochemistry, 2013, 442, 127-129
2.411Citations (PDF)
158Diagnostic Chest X-Rays and Breast Cancer Risk before Age 50 Years for BRCA1 and BRCA2 Mutation Carriers1.123Citations (PDF)
159Evaluation of a 5-Tier Scheme Proposed for Classification of Sequence Variants Using Bioinformatic and Splicing Assay Data: Inter-Reviewer Variability and Promotion of Minimum Reporting Guidelines
Human Mutation, 2013, 34, 1424-1431
4.569Citations (PDF)
160Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles
PLoS ONE, 2013, 8, e55681
2.3100Citations (PDF)
161Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E
PLoS ONE, 2013, 8, e54727
2.332Citations (PDF)
162A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers1.124Citations (PDF)
163High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers2.413Citations (PDF)
164Genome-wide association analysis identifies three new breast cancer susceptibility loci
Nature Genetics, 2012, 44, 312-318
25.2271Citations (PDF)
165Interleukin‐6 promoter variants, prostate cancer risk, and survival
Prostate, 2012, 72, 1701-1707
2.122Citations (PDF)
166Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers4.883Citations (PDF)
167Ovarian cancer susceptibility alleles and risk of ovarian cancer inBRCA1andBRCA2mutation carriers
Human Mutation, 2012, 33, 690-702
4.535Citations (PDF)
168Design Considerations for Massively Parallel Sequencing Studies of Complex Human Disease
PLoS ONE, 2011, 6, e23221
2.320Citations (PDF)
169Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue2.456Citations (PDF)
170Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer
International Journal of Cancer, 2011, 129, 2256-2262
4.3103Citations (PDF)
1717q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium
Journal of Medical Genetics, 2011, 48, 698-702
3.85Citations (PDF)
172The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain
Journal of Medical Genetics, 2011, 48, 703-704
3.813Citations (PDF)
173Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Human Molecular Genetics, 2011, 20, 4732-4747
2.937Citations (PDF)
174Body Mass Index in Early Adulthood and Endometrial Cancer Risk for Mismatch Repair Gene Mutation Carriers
Obstetrics and Gynecology, 2011, 117, 899-905
1.925Citations (PDF)
175Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
British Journal of Cancer, 2011, 105, 1934-1939
5.55Citations (PDF)
176The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant2.46Citations (PDF)
177The 4q27 locus and prostate cancer risk
BMC Cancer, 2010, 10,
2.98Citations (PDF)
178Sibship analysis of associations between SNP haplotypes and a continuous trait with application to mammographic density
Genetic Epidemiology, 2010, 34, 309-318
3.110Citations (PDF)
179Letter in response to “Identifying Lynch syndrome” by de la Chapelle et al.
International Journal of Cancer, 2010, 126, 2757-2758
4.31Citations (PDF)
180Plasma concentration of Propionibacterium acnes antibodies and prostate cancer risk: results from an Australian population-based case–control study
British Journal of Cancer, 2010, 103, 411-415
5.525Citations (PDF)
181Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations
British Journal of Cancer, 2010, 103, 1103-1108
5.530Citations (PDF)
182A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population
Nature Genetics, 2010, 42, 885-892
25.2317Citations (PDF)
183Molecular characterization of breast cancer in young Brazilian women0.810Citations (PDF)
184Family-based association study of IGF1 microsatellites and height, weight, and body mass index
Journal of Human Genetics, 2010, 55, 255-258
2.04Citations (PDF)
185Association of ESR1 gene tagging SNPs with breast cancer risk
Human Molecular Genetics, 2009, 18, 1131-1139
2.987Citations (PDF)
186Familial Correlations in Postmenopausal Serum Concentrations of Sex Steroid Hormones and Other Mitogens: A Twins and Sisters Study4.123Citations (PDF)
187Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk2.45Citations (PDF)
188A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2
Nature Genetics, 2009, 41, 996-1000
25.2296Citations (PDF)
189Are PALB2 mutations associated with increased risk of male breast cancer?2.420Citations (PDF)
190The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels
BJU International, 2008, 101, 492-496
3.213Citations (PDF)
191The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
British Journal of Cancer, 2008, 98, 1457-1466
5.5490Citations (PDF)
192Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers
Journal of Medical Genetics, 2008, 45, 409-410
3.81Citations (PDF)
193Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium1.1151Citations (PDF)
194The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis2.421Citations (PDF)
195The Common Variant rs1447295 on Chromosome 8q24 and Prostate Cancer Risk: Results from an Australian Population-Based Case-Control Study1.164Citations (PDF)
196Mammographic Density and Candidate Gene Variants: A Twins and Sisters Study1.131Citations (PDF)
1975α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia4.361Citations (PDF)
198Medical radiation exposure and breast cancer risk: Findings from the Breast Cancer Family Registry4.363Citations (PDF)
199A range of simple summary genome-wide statistics for detecting genetic linkage using high density marker data
Genetic Epidemiology, 2007, 31, 565-576
3.13Citations (PDF)
200Genome-wide association study identifies novel breast cancer susceptibility loci
Nature, 2007, 447, 1087-1093
37.92,211Citations (PDF)
201Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies
BMC Genomics, 2007, 8, 299
3.326Citations (PDF)
202Is MSH2 a breast cancer susceptibility gene?
Familial Cancer, 2007, 7, 151-155
1.46Citations (PDF)
203BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 501.1120Citations (PDF)
204A genome wide linkage search for breast cancer susceptibility genes
Genes Chromosomes and Cancer, 2006, 45, 646-655
3.0114Citations (PDF)
205The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers1.126Citations (PDF)
206Macrophage Inhibitory Cytokine-1 H6D Polymorphism, Prostate Cancer Risk, and Survival1.134Citations (PDF)
207Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability2.48Citations (PDF)
208TwoATM variants and breast cancer risk
Human Mutation, 2005, 25, 594-595
4.544Citations (PDF)
209Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer1.178Citations (PDF)
210The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia1.180Citations (PDF)
211Genetic Variants in the Vitamin D Receptor Gene and Prostate Cancer Risk1.134Citations (PDF)
212Macrophage Scavenger Receptor 1 999C>T (R293X) Mutation and Risk of Prostate Cancer1.121Citations (PDF)
213Title is missing!
Breast Cancer Research, 2005, 7, R176
4.846Citations (PDF)
214Cytomegalovirus, Epstein–Barr virus and risk of breast cancer before age 40 years: a case–control study
British Journal of Cancer, 2004, 90, 2149-2152
5.545Citations (PDF)
215Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics
Human Genetics, 2003, 112, 542-551
2.944Citations (PDF)
216A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation inBRCA1
Human Mutation, 2003, 22, 86-91
4.510Citations (PDF)
217Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
British Journal of Cancer, 2003, 89, 1661-1663
5.537Citations (PDF)
218Molecular Pathologic Analysis Enhances the Diagnosis and Management of Muir-Torre Syndrome and Gives Insight Into Its Underlying Molecular Pathogenesis3.545Citations (PDF)
219Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients1.561Citations (PDF)
220Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients1.563Citations (PDF)
221HRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years4.618Citations (PDF)
222De Novo BRCA1 Mutation in a Patient with Breast Cancer and an Inherited BRCA2 Mutation6.559Citations (PDF)
223CFTR ΔF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study
1998, 79, 487-489
20Citations (PDF)
224BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer
British Journal of Cancer, 1998, 79, 34-39
5.573Citations (PDF)
225Coexistent T-Cell Lymphoblastic Lymphoma and an Atypical Myeloproliferative Disorder Associated with t(8;13)(p21;q14)1.09Citations (PDF)
226Chromosomal Localization of the Human P2y6Purinoceptor Gene and Phylogenetic Analysis of the P2y Purinoceptor Family
Genomics, 1997, 44, 127-130
2.813Citations (PDF)
227COEXISTENT T-CELL LYMPHOBLASTIC LYMPHOMA AND AN ATYPICAL MYELOPROLIFERATIVE DISORDER ASSOCIATED WITH t(8;13)(p21;q14)1.08Citations (PDF)
228Spatiotemporally Exact cDNA Libraries from Quail Embryos: A Resource for Studying Neural Crest Development and Neurocristopathies
Genomics, 1996, 38, 206-214
2.84Citations (PDF)
229Molecular Analysis in the Diagnosis of Pediatric Lymphomas1.08Citations (PDF)
230Molecular cloning and sequencing of a novel human P2 nucleotide receptor3.414Citations (PDF)
231EWS/FLI-1 Fusion Transcript Detection and MIC2 Immunohistochemical Staining in the Diagnosis of Ewing's Sarcoma1.015Citations (PDF)
232Primary Cutaneous Ewing??s Sarcoma/Peripheral Primitive Neuroectodermal Tumors in Childhood1.459Citations (PDF)
233Active tyrosine phosphatase in immunoprecipitates of multiple isoforms of Ly-5
Cellular Signalling, 1990, 2, 299-304
3.50Citations (PDF)
234Cohort Profile: Melbourne Atopy Cohort study (MACS)4.922Citations (PDF)
235Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses4.30Citations (PDF)
236Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis4.60Citations (PDF)
237Climate-related disasters and biological aging based on DNA methylation: a twin and family study in Australian women4.91Citations (PDF)